Viraferonpeg and paralysis Patient Reports February 11, 2012

Viraferonpeg Side Effects Report #5988881-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Dec 01, 2008. Female patient, 74 years of age, weighting 160.9 lb, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, dysstasia, fatigue, haemoglobin decreased, paralysis , vomiting. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #6075730-9
Viraferonpeg side effect was reported by a Physician from FRANCE on Jan 28, 2009. Female patient, 74 years of age, weighting 160.9 lb, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: fatigue, haemoglobin decreased, paralysis , rhabdomyolysis, speech disorder, vomiting. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, PLAVIX. Patient was hospitalized. Patient recovered.

Viraferonpeg Side Effects Report #5122656-0
Viraferonpeg side effect was reported by a Health Professional from UNITED KINGDOM on Sept 18, 2006. Male patient, 42 years of age, was diagnosed with hepatitis c  and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: acidosis, cardio-respiratory arrest, epilepsy , haemodialysis, hepatic failure, hepatitis acute, nephritis, paralysis , renal failure. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, LAMOTRIGINE, PHENYTOIN. Patient died on 06/30/2006.

Viraferonpeg Side Effects Report #4622151-9
Viraferonpeg side effect was reported by a Consumer or non-health professional from on Mar 17, 2005. Female patient, 35 years of age, was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: abasia, paralysis , suicidal ideation. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL. Patient was hospitalized and became disabled. Patient recovered.